Evidence map›Paper›PMID 39053958›Full record

Trial reportBMJ open2024

Development and application of a qualitative rapid analysis framework in a hybrid trial within primary care.

Amy Mathieson, Rebecca Elvey, Paul Wilson

Registry-linked trialAbstract readRandomized Controlled TrialClinical Trial, Phase III
In one paragraph

Trial report in BMJ open, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It reports registered trial NCT04807400. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04807400 phase3completed

A Phase IIIb, Multicentre, Randomised Controlled Study to Evaluate the Implementation, Preference and Utility for Administration of Inclisiran Sodium in Participants With Atherosclerotic Cardiovascular Disease (ASCVD) or ASCVD-risk Equivalents and Elevated Low Density Lipoprotein Cholesterol (LDL-C) Using a Primary Care Models in the NHS.

Ran2021Enrolled892Registered outcomes7Posted comparisons8ConditionsAtherosclerotic Cardiovascular Disease, Atherosclerotic Cardiovascular Disease Risk Equivelents, Elevated Low Density Lipoprotein CholesterolArmsBackground lipid lowering therapy, Behavioural Support, Inclisiran
Open the trial in the graph
3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Trial
  2. Rapid Pre-Implementation Evaluation for Multi-Specialty Surgical Trials: Informing Context-Specific Adaptations.Annals of surgery open : perspectives of surgical history, education, and clinical approaches · 2026
    Article
  3. Development of S-IMCICA_V.2: A User-Centered Educational and Decision-Support mHealth App for Early Detection of Childhood Cancer.Journal of cancer education : the official journal of the American Association for Cancer Education · 2026
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Amy MathiesonCentre for Primary Care and Health Services Research, Division of Population Health, The University of Manchester, Manchester, UK amy.mathieson@manchester.ac.uk.ORCID 0000-0002-5360-3644
Rebecca ElveyCentre for Primary Care and Health Services Research, Division of Population Health, The University of Manchester, Manchester, UK.ORCID 0000-0003-3754-4979
Paul WilsonCentre for Primary Care and Health Services Research, Division of Population Health, The University of Manchester, Manchester, UK.ORCID 0000-0002-2657-5780

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

contextIn the context of iterative feedback loops to support real-time policy decision making, and an emphasis on speeding up adoption of evidence-based interventions, qualitative healthcare researchers are increasingly expected to produce rapid results and products. Traditional qualitative methods have been adapted for this purpose.

objectiveTo develop and apply a rapid analysis framework in a process evaluation for the VICTORION-Spirit study; a ground-breaking hybrid trial examining real-world delivery of inclisiran-a cholesterol-lowering treatment-in primary care.

designWe developed a rapid analysis framework, using a summary template, to analyse data from semistructured telephone interviews.

settingPrimary care in Greater Manchester, UK.

participantsPatients who had received inclisiran as part of the VICTORION-Spirit trial (56), providers delivering inclisiran (28) and representatives from the Academic Health Science Network (8) participated in the original study.

resultsThe rapid analysis framework we developed and applied comprised six steps: (1) creating a summary template based on the five Consolidated Framework for Implementation Research domains; (2) test-driving, refining and finalising the summary template; (3) completing the template soon after each interview using field notes; (4) discussing analysis as a team; (5) transferring summaries to a matrix; and (6) using the summary matrix to inform presentations and interim reports for stakeholders. Our rapid analysis framework saved time and improved efficiency, as we were able to feedback barriers to stakeholders in real time via presentations.

conclusionsRapid analysis in applied healthcare research can produce timely and trustworthy findings. Our rapid analysis framework would be useful within studies where there is a need to feedback to stakeholders and adjust implementation strategies accordingly in real time. Thus, supporting successful implementation efforts and accelerating adoption. TRIAL REGISTRATION NUMBER: NCT04807400, 19/03/2021.

Indexed as

Primary Health CareQualitative ResearchHumansInterviews as TopicUnited KingdomClinical TrialImplementation SciencePatient ParticipationPrimary CareQUALITATIVE RESEARCHSTATISTICS & RESEARCH METHODS

Identifiers

PMID39053958
PMCPMC11284935

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.